DOW JONES23,221.68+567.82 2.51%
S&P 5002,720.70+61.29 2.30%
NASDAQ8,035.69+148.43 1.88%

Catabasis Pharmaceuticals Q4 EPS $(0.55) Beats $(0.61) Estimate

Catabasis Pharmaceuticals (NASDAQ:CATB) reported quarterly losses of $(0.55) per share which beat the analyst consensus estimate of $(0.61) by 9.84 percent. This is a 35.29 percent increase over losses of $(0.85) per

Benzinga · 03/10/2020 12:12

Catabasis Pharmaceuticals (NASDAQ:CATB) reported quarterly losses of $(0.55) per share which beat the analyst consensus estimate of $(0.61) by 9.84 percent. This is a 35.29 percent increase over losses of $(0.85) per share from the same period last year.